Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1995-06-06
1998-12-01
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
530311, 514806, A61K 5108, A61K 3702
Patent
active
058434011
ABSTRACT:
This invention relates to therapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing labeled radiodiagnostic agents. Specifically, the invention relates to peptide derivatives and analogs of somatostatin, and embodiments of such peptides labeled with technetium-99m (Tc-99m), as well as methods and kits for making, radiolabeling and using such peptides to image sites in a mammalian body. The invention also relates to peptide derivatives and analogues of somatostatin labeled with rhemium-186 (.sup.186 Re) and rhenium-188 (.sup.188 Re), and methods and kits for making, radiolabeling and using such peptides therapeutically in a mammalian body.
REFERENCES:
patent: 4235886 (1980-11-01), Freidinger
patent: 4244947 (1981-01-01), Abraham et al.
patent: 4444690 (1984-04-01), Fritzberg
patent: 4472509 (1984-09-01), Gansow et al.
patent: 4485101 (1984-11-01), Coy et al.
patent: 4611054 (1986-09-01), Freidinger
patent: 4612366 (1986-09-01), Nutt
patent: 4650787 (1987-03-01), Schally et al.
patent: 4684620 (1987-08-01), Hruby et al.
patent: 4853371 (1989-08-01), Coy et al.
patent: 4871717 (1989-10-01), Coy et al.
patent: 4904642 (1990-02-01), Coy et al.
patent: 4988496 (1991-01-01), Srinivason et al.
patent: 5073541 (1991-12-01), Taylor et al.
patent: 5095111 (1992-03-01), Lever et al.
patent: 5196510 (1993-03-01), Rodwell
patent: 5225180 (1993-07-01), Dean et al.
patent: 5382654 (1995-01-01), Lyle et al.
patent: 5395946 (1995-03-01), Goedemans et al.
patent: 5405597 (1995-04-01), Dean et al.
patent: 5409894 (1995-04-01), Handley et al.
patent: 5443815 (1995-08-01), Dean et al.
patent: 5443816 (1995-08-01), Zamora et al.
patent: 5460785 (1995-10-01), Rhodes et al.
patent: 5508020 (1996-04-01), Dean et al.
patent: 5620675 (1997-04-01), McBride et al.
Gero et al., "Synthesis and Biological Activity of a cyclic pseudo-hexapeptide analog of somatostatin", Biochem. Biophys. Res. Comm., vol. 120, No. 3, pp. 840-845, May 1984.
Albert et al., "A Somatostatin Analogue to Image SS-Receptor-Positive Abstract LM10, 12.sup.th American Peptide Symposium: 1991.
Arano et al., "A Novel Bifunctional Metabolisable Linker For The Conjugation Of Antibodies With Radionucleotides," Bioconj. Chem, vol. 2, No. 2, 1991, pp. 71-76.
Bakker et al., "In Vivo Use of a Radioiodinated Somatostatin Analogue: Dynamics, Metabolism, and Binding to Somatostatin Receptor-Positive Tumors in Man," J. Nucl. Med. 32:1184-1189 (1991).
Bakker et al., "Receptor Scintigraphy with a Radioiodinated Somatostatin Analogue: Radiolabeling, Purification, Biologic Acitivity, and In Vivo Applications in Animals," J. Nucl. Med. 31:1501-1509 (1990).
Bean et al., "Identification of a thioether byproduct in the synthesis of a cyclic disulfide peptide by tandem mass spectrometry," Peptides; Chemistry, Structure and Biology, ESCOM, Leiden 1990, pp. 443-445, Rivier et al.
Bomanji et al., "A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octrotreoide) in metastic carcinoid tumors," J. Nucl. Med. 33:1121-1124 (1992).
Bryson, "Protecting Groups In The Preparation Of Thiolate Complexes Of Technetium," Inorganic Chemistry vol. 29, No. 16, Aug. 8, 1990, pp. 2948-2951.
Byrne & Tolman, "Technetium-99m Bifunctional Chelating Agent--Thiolactone for Coupling to Biomolecules, N.sub.2 S.sub.2 Ligand for Chalation to Technetium," J. Nucl. Med. 24:126 (1983).
Cox et al., "Technetium Labeled Somatostatin: A Potential Agent for In Vivo Tumour Localization," Abstract, 7.sup.th International Symposium on Radiopharmacology, p. 16 (1991).
Faglia et al., "In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog 73:850-856 (1991).
Khaw et al., "Technetium-99m Labeling of Antibodies to Cardiac Myosin Fab and to Human Fibrinogen," J. Nucl. Med. 23:1011-1019 (1982).
Krenning et al., "Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: Metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide," J. Nucl. Med. 33:652-658 (1992). Neuro-endocrine Tumors," J. Nucl. Med. 32:981 Abstract #305 (1991).
Lamberts, "Receptors on Tumors Studied with Radionuclide Scintigraphy", J. Nucl. Med 32:1189-1191 (1991).
Larson, "Receptors on Tumors Studied with Radionuclide Scintigraphy," J. Nucl. Med. 32:1189-1191 (1991).
Li et al., "A New Bifunctional Chelating Agent Alpha, Epsilon-N,N'-bis (L-Cyteinyl)-L -Lysine For Radiolabeleing of Monoclonal antibodies with TC-99M," Chemical Abstracts, Oct. 14, 1991, vol. 115, No. 15, abstract No. 159733, p. 1001, col. 2.
Rhodes, "Considerations in the Radiolabeling of Albumin," Sem. Nucl. Med. 4:281-293 (1974).
Zubay, Biochemistry (2d ed.), 1988, (MacMillan Publishing: New York), p. 33 .
Dean Richard T.
Lister-James John
Dees Jos,e G.
Diatide, Inc.
Hartley Michael G.
McDaniels Patricia A.
Noonan Kevin E.
LandOfFree
Radioactively labeled somatostatin-derived peptides for imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioactively labeled somatostatin-derived peptides for imaging , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioactively labeled somatostatin-derived peptides for imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2393204